Goldman Sachs analyst Michael Peet removed Elders from the firm’s Conviction List but keeps a Buy rating on the shares with a A$13.20 price target. The analyst believes the stock’s current valuation has more than factored in any cyclical earnings impact and "significantly undervalues the quality of the company."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly